Sunshine Biopharma Inc. - Common stock (NQ:SBFM)

0.3673 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EDT, May 20, 2026 Add to My Watchlist

Price and Volume

Volume	120,071,602
Open	0.3673
Bid (Size)	0.5450 (1,400)
Ask (Size)	0.5460 (5,500)
Prev. Close	0.3673
Today's Range	0.3673 - 0.3673
52wk Range	0.2812 - 2.430
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

What's going on in today's pre-market session ↗

Today 8:30 EDT

Via Chartmill

Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Amoxicillin

Today 7:00 EDT

Via ACCESS Newswire

Performance

YTD	-71.3%	-71.3%
1 Month	-64.2%	-64.2%
3 Month	-68.9%	-68.9%
6 Month	-74.0%	-74.0%
1 Year	-75.4%	-75.4%

More News

Top movers in Wednesday's session ↗

May 20, 2026

Via Chartmill

BioMedNewsBreaks — Sunshine Biopharma Inc. (NASDAQ: SBFM) Closes $6 Million Public Offering

May 20, 2026

Via Investor Brand Network

Sunshine Biopharma Stock Powers Ahead Following Launch Of Generic Cholesterol-Lowering Drug By Canadian Unit ↗

October 16, 2025

Via Stocktwits

Stay updated with the stocks that are on the move in today's pre-market session. ↗

May 20, 2026

Via Chartmill

In today's session, these stocks are experiencing unusual volume. ↗

May 19, 2026

Via Chartmill

Sunshine Biopharma Inc. Announces Closing of up to $18.0 Million Public Offering

May 19, 2026

Via ACCESS Newswire

Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering

May 18, 2026

Via ACCESS Newswire

Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year

April 06, 2026

Via ACCESS Newswire

Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)

October 28, 2025

Via ACCESS Newswire

Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea

October 28, 2025

Via ACCESS Newswire

Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline

October 20, 2025

Via ACCESS Newswire

Sunshine Biopharma Stock Is Surging Thursday: Here's What's Happening ↗

October 16, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 16, 2025

Via Benzinga

Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin

October 16, 2025

Via ACCESS Newswire

Sunshine Biopharma Stock is 34% Higher Since September as Investors Reward Performance Combined with Innovation (NASDAQ: SBFM)

October 16, 2025

Via AB Newswire

Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)

October 14, 2025

Via ACCESS Newswire

Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)

October 14, 2025

Via ACCESS Newswire

Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience

October 14, 2025

Via ACCESS Newswire

Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections

October 09, 2025

Via ACCESS Newswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

August 12, 2025

Via Benzinga

Sunshine Biopharma Stock Soars After Launch Of First Biosimilar In $10B Canadian Market: Retail Bulls Charge In ↗

July 02, 2025

Via Stocktwits

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 02, 2025

Via Benzinga

Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market

July 02, 2025

Via ACCESS Newswire

Frequently Asked Questions

Is Sunshine Biopharma Inc. - Common stock publicly traded?

Yes, Sunshine Biopharma Inc. - Common stock is publicly traded.

What exchange does Sunshine Biopharma Inc. - Common stock trade on?

Sunshine Biopharma Inc. - Common stock trades on the Nasdaq Stock Market

What is the ticker symbol for Sunshine Biopharma Inc. - Common stock?

The ticker symbol for Sunshine Biopharma Inc. - Common stock is SBFM on the Nasdaq Stock Market

What is the current price of Sunshine Biopharma Inc. - Common stock?

The current price of Sunshine Biopharma Inc. - Common stock is 0.3673

When was Sunshine Biopharma Inc. - Common stock last traded?

The last trade of Sunshine Biopharma Inc. - Common stock was at 05/20/26 04:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.